Published in Stroke on January 01, 1994
Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry (1992) 4.16
A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci (1993) 3.16
Periventricular and white matter magnetic resonance imaging hyperintensities do not differ between Alzheimer's disease and normal aging. Arch Neurol (1990) 1.78
'Normal' 99mTc-HmPAO distribution in large subacute middle cerebral artery infarct. Stroke (1994) 1.39
Increased intestinal permeability in bronchial asthma. J Allergy Clin Immunol (1996) 1.11
[Paragangliomas: clinical and secretory profile. Result of 39 cases]. Ann Chir (2004) 1.09
Prospective evaluation of the impact of [18F]fluoro-2-deoxy-D-glucose positron emission tomography of resectable colorectal liver metastases. Br J Surg (2005) 1.09
Could Wallerian degeneration contribute to "leuko-araiosis" in subjects free of any vascular disorder? J Neurol Neurosurg Psychiatry (1991) 1.07
Noninvasive imaging of insulinomas and gastrinomas with endoscopic ultrasonography and somatostatin receptor scintigraphy. Surgery (1998) 1.01
SPECT data in a case of secondary Capgras delusion. Psychopathology (1994) 0.97
Radionuclide scanning in parathyroid diseases. Br J Surg (1998) 0.97
Alzheimer's disease and frontotemporal dementia are differentiated by discriminant analysis applied to (99m)Tc HmPAO SPECT data. J Neurol Neurosurg Psychiatry (2000) 0.94
FDG-PET in the assessment of patients with follicular lymphoma treated by ibritumomab tiuxetan Y 90: multicentric study. Ann Oncol (2010) 0.93
Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody. J Nucl Med (1998) 0.91
Chromogranin A assay and (131)I-MIBG scintigraphy for diagnosis and follow-up of pheochromocytoma. J Nucl Med (2001) 0.90
[Cerebral blood flow disturbances after anterior choroidal artery infarcts. Anatomical and functional correlates]. Rev Neurol (Paris) (2001) 0.88
Evidence for atrophy of the corpus callosum in Alzheimer's disease. Eur Neurol (1994) 0.87
Essential hypertension: first reason for persistent hypertension after unilateral adrenalectomy for primary aldosteronism? Surgery (1998) 0.87
Questionability of the benefits of routine laparotomy as the surgical approach for pheochromocytomas and abdominal paragangliomas. Surgery (1996) 0.86
Tomographic measurements of regional cerebral blood flow in progressive supranuclear palsy and Parkinson's disease. Acta Neurol Scand (1995) 0.86
Symptomatic vasospasm after subarachnoid haemorrhage: assessment of brain damage by diffusion and perfusion-weighted MRI and single-photon emission computed tomography. Neuroradiology (2002) 0.86
3D mutifractal analysis: a new tool for epileptic fit sources detection in SPECT images. Conf Proc IEEE Eng Med Biol Soc (2008) 0.83
[Correlation of thalamic aphasia and cerebral blood flow]. Rev Neurol (Paris) (1990) 0.82
Fractal features for localization of temporal lobe epileptic foci using SPECT imaging. Comput Biol Med (2010) 0.81
Stable labelling of serum albumin microspheres with gallium-68. Int J Rad Appl Instrum A (1986) 0.81
Tumour size: the only predictive factor for 131I MIBG uptake in phaeochromocytoma and paraganglioma. Aust N Z J Surg (1999) 0.81
Remote regional cerebral blood flow consequences of focused infarcts of the medulla, pons and cerebellum. J Nucl Med (1999) 0.81
Technetium HMPAO SPECT study in dementia with Lewy bodies, Alzheimer's disease and idiopathic Parkinson's disease. J Nucl Med (1999) 0.80
Prospective and serial study of primary amyloidosis with serum amyloid P component scintigraphy: from diagnosis to prognosis. Am J Med (1996) 0.80
Tomographic measurement of cerebral blood flow by the 68Ga-labelled-microsphere and continuous-C15O2-inhalation methods. Eur J Nucl Med (1985) 0.80
[Alzheimer's disease: study by single photon emission tomography (Hm PAO Tc99m)]. Rev Neurol (Paris) (1989) 0.80
[Residual deficit of verbal recall after a left internal cerebral vein infarct]. Rev Neurol (Paris) (1998) 0.80
[Dystonia and tremor in bilateral lesion of the posterior mesencephalon and the vermis]. Rev Neurol (Paris) (1996) 0.79
[Disruptions of hemispheric blood flow and deep cerebral hematomas]. Rev Neurol (Paris) (1986) 0.79
Xerostomia in systemic sclerosis: systematic evaluation by salivary scintigraphy and lip biopsy in thirty-four patients. Arthritis Rheum (1994) 0.79
Crossed hemispheric diaschisis in unilateral cerebellar lesions. Stroke (1992) 0.79
[The delusion of place: contribution of the measurement of cerebral deficit]. Cortex (1988) 0.79
[HmPaO Tc as an indicator of local cerebral blood flow: quantified study compared to the xenon 133 inhalation method]. Ann Radiol (Paris) (1988) 0.79
[The association of asthma and gastroesophageal reflux: strategy of paraclinical studies]. Rev Mal Respir (1985) 0.79
PET study and neuropsychological assessment of a long-lasting post-encephalitic parkinsonism. J Neural Transm (Vienna) (1998) 0.78
Localization of abnormal parathyroid glands with jugular sampling for parathyroid hormone, and subtraction scanning with sestamibi or tetrofosmine. Aust N Z J Surg (1998) 0.78
[Right unilateral auditory agnosia following left lenticular hemorrhage]. Rev Neurol (Paris) (1991) 0.78
Iodine-123-Tyr-3-octreotide uptake in pancreatic endocrine tumors and in carcinoids in relation to hormonal inhibition by octreotide. J Nucl Med (1994) 0.78
Simultaneous determination of pulmonary and intestinal permeability in patients with alcoholic liver cirrhosis. Eur J Nucl Med (2001) 0.78
Perfusion mapping with Tc-HMPAO in cerebral haematomas. J Neurol Neurosurg Psychiatry (1991) 0.78
Comparisons of dosimetric approaches for fractionated radioimmunotherapy of non-Hodgkin lymphoma. Q J Nucl Med Mol Imaging (2012) 0.78
A new method based on both fuzzy set and possibility theories for tumor volume segmentation on PET images. Conf Proc IEEE Eng Med Biol Soc (2008) 0.77
The use of SPECT in a multidisciplinary memory clinic. Dement Geriatr Cogn Disord (1997) 0.77
White-matter lesions on CT in Alzheimer patients. Acta Neurol Scand (1991) 0.77
[Cerebral blood flow deficit and thalamic infarcts. Topographic and neuropsychological confrontations]. Rev Neurol (Paris) (1989) 0.77
[Importance of cerebral tomoscintigraphy using technetium-labeled sestamibi in the differential diagnosis of current tumor vs. radiation necrosis in subtentorial glial tumors in the adult]. Neurochirurgie (1999) 0.77
Efficacy of iodine-131 6beta-methyl-iodo-19-norcholesterol scintigraphy and computed tomography in patients with primary aldosteronism. Eur J Nucl Med (1999) 0.77
Comparison between Leukoscan (Sulesomab) and Gallium-67 for the diagnosis of osteomyelitis in the diabetic foot. Diabetes Metab (2005) 0.76
Visual hallucinations with written words in a case of left parietotemporal lesion. J Neurol Neurosurg Psychiatry (1994) 0.76
Scintiscans and carcinoid tumors. Surgery (1994) 0.76
[Reoperation for persistent or recurrent primary hyperparathyroidism. Seventy-seven cases among 1888 operated patients]. Ann Chir (2004) 0.76
An easy-to-use phantom and protocol for weekly PET quality assessment: a multicenter study. Med Phys (2008) 0.75
Correlation of parathyroid scanning and anatomy in 261 unselected patients with sporadic primary hyperparathyroidism. Surgery (1999) 0.75
Comparison of technetium-99m methoxyisobutylisonitrile and gallium-67 citrate scanning in the assessment of lymphomas. Eur J Nucl Med (1995) 0.75
Patterns of dementia in Alzheimer's disease. J Nucl Med (1992) 0.75
Comparison of somatostatin analogue and metaiodobenzylguanidine scintigraphy for the detection of carcinoid tumours. Eur J Nucl Med (1996) 0.75
Cognitive and psychiatric impairment in herpes simplex virus encephalitis suggest involvement of the amygdalo-frontal pathways. J Neurol (1996) 0.75
[Bilateral paramedian thalamic infarction: a case with MRI and gamma-emission tomography]. Rev Neurol (Paris) (1989) 0.75
[Diagnosis of Pott's disease by radionuclide imaging with gallium]. Nouv Presse Med (1978) 0.75
[Simultaneous scintigraphy exploration using MDP - 99 Tc and 67GA in infectious osteoarticular pathology. Initial results]. Rev Rhum Mal Osteoartic (1983) 0.75
99mTc-HMPAO washout in prognosis of stroke. Lancet (1989) 0.75
[Hexamethylpropyleneamine-oxime--Tc 99m: a new indicator of cerebral perfusion]. Presse Med (1987) 0.75
[Simultaneous study of the placental, myometrial and cervical circulations (indium 113 and anemometric thermometry). 2. Effect of xanthinol nicotinate]. J Gynecol Obstet Biol Reprod (Paris) (1976) 0.75
[Value of gallium scintigraphy in digestive surgery]. Lille Med (1978) 0.75
[Regional cerebral blood flow and its reactivity to acetazolamide in transient ischemic attacks. Study of 20 cases by gamma emission tomography]. Rev Neurol (Paris) (1987) 0.75
[Validity of early scintigraphy with 67 gallium citrate in the detection of abdominal collections of pus]. Lille Med (1979) 0.75
[A critical study of technetium 99m and xenon 133 lung scintigraphy in patients with cystic fibrosis]. Sem Hop (1983) 0.75
[Modern methods (tomographic) of measuring the cerebral blood flow in man]. LARC Med (1983) 0.75
Fast Diagnosis (6h) of clinically silent pyonephrosis by combined use of 99mTc-MDP and 67Ga citrate. Eur J Nucl Med (1981) 0.75
Cerebral blood flow in lateral medullary infarcts. Stroke (1995) 0.75
[Brain scanning with 201 thallium. Comparative study with D.T.P.A. 99mTc brain radioangiogram]. J Radiol (1982) 0.75
Lateral ventricle visualization during brain scanning with Tc-DTPA. Eur J Nucl Med (1980) 0.75
[Computed tomographic measurement of the cerebral blood flow with xenon-133]. Rev Prat (1987) 0.75
[Measurement of local cerebral blood flow by dynamic gamma emission tomography: 1st results in the evaluation of distal juvenile ischemia]. Ann Radiol (Paris) (1984) 0.75
New time-shifted Z-score and Student's test in fMRI. Conf Proc IEEE Eng Med Biol Soc (2006) 0.75
[Diagnostic value of 3-stage bone scintigraphy. Comparison with classical bone scintigraphy]. Rev Rhum Mal Osteoartic (1988) 0.75
[Study of some agents modifying in vivo distribution of gallium-67 citrate]. Lille Med (1979) 0.75
[Weight loss and dyspnea in a 46-year-old woman]. Rev Med Interne (2011) 0.75
[Value of splenic scintigraphy in the assessment of the extension of Hodgkin's disease]. Lille Med (1977) 0.75
[A critical study of Technetium 99m and Xenon 133 lung scintigraphy in patients with cystic fibrosis]. Ann Pediatr (Paris) (1983) 0.75
[Comparative action of L-dopa and bromocriptine on thyreostimulating hormone (T.S.H.) in primary hypothyroïdism (author's transl)]. Nouv Presse Med (1979) 0.75
[Water diffusion and measurement of cerebral blood flow by C15O2 inhalation]. Int J Nucl Med Biol (1983) 0.75
[Value of the comparison of tissue distribution of Rb and K, studied by atomic absorption spectrophotometry and by radioisotopes]. Lille Med (1976) 0.75
[Isotope methods in neurology]. Soins (1987) 0.75
[Scintigraphy in the evaluation of painful arthroplasties. Simultaneous use of technetium and gallium]. Rev Chir Orthop Reparatrice Appar Mot (1984) 0.75
[Simultaneous study of the placental, myometrial and cervical circulations (indium 113 and anemometric thermometry) I. Technic]. J Gynecol Obstet Biol Reprod (Paris) (1974) 0.75
[Measurement of local cerebral blood flow with gamma emission tomography: normal values and quantified criteria for interpretation]. Ann Radiol (Paris) (1986) 0.75
Mismatch between iodine-123 and xenon-133 SPECT rCBF measurement. Clin Nucl Med (1986) 0.75